We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.50
Bid: 93.00
Ask: 96.00
Change: -1.00 (-1.05%)
Spread: 3.00 (3.226%)
Open: 95.50
High: 95.50
Low: 94.50
Prev. Close: 95.50
GATC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Succession

15 Mar 2022 07:00

RNS Number : 7361E
Gattaca PLC
15 March 2022
 

15 March 2022

 

Gattaca plc

 

("Gattaca" or the "Group")

 

 

Board Succession

 

 

Gattaca plc, the specialist Engineering and Technology recruitment solutions business, announces that Kevin Freeguard will be stepping down from the Board at the end of March this year and retire from Gattaca at the end of April 2022. Having joined the Group in October 2018, it was Kevin's original intention to leave at the end of this year but he felt, and the Board agreed, that given the scale of further improvement required in the business, an earlier change of leadership was in the Group's interest.

 

Having been with the Group since June 2017 and serving under two CEOs, Salar Farzad has also agreed that he will leave Gattaca at the same time, stepping down from the Board at the end of March and leaving Gattaca at the end of April 2022. He and the Board believe that the business will be best served by a CFO who can partner with the new CEO for the long term.

 

In line with the Group's succession plan, Matt Wragg, currently Chief Customer Officer, is appointed to succeed Kevin as Chief Executive Officer. Matt will join the Board as CEO with effect from 1 April 2022. Matt has been with Gattaca for 20 years and has substantial knowledge of the recruitment industry and a deep understanding of Gattaca. He has been a member of the Management Board since 2016.

 

As part of that succession plan, Oliver Whittaker will succeed Salar as CFO, subject to the successful completion of due diligence by the Group's Nominated Advisor ('Nomad'). Oliver joined Gattaca in 2017 as Group Director of Financial Planning where he has actively supported the Board and works closely with Matt. Oliver was previously UK Finance Director for Fitness First, has held roles with Serco and IBM, and is an ACA qualified accountant.

 

 

Patrick Shanley, Chairman, said:

 

"The Board would like to thank Kevin and Salar for their leadership over the last 4/5 years, including the challenges during the pandemic. They have been instrumental to the significant reduction in net debt, the establishment of our new operating model and implementing an integrated global technology platform. Thanks to their enormous contribution, the Group is significantly stronger than it was 5 years ago.

 

Whilst Gattaca has been growing, we recognise that this growth is not in line with that of our market. Matt and Oliver have a thorough understanding of the business and have worked together for several years. They are well-positioned to deliver the necessary short-term improvement and develop the business over the long term."

 

 

Matthew Howard Wragg, 42, is currently a director of, or during the past five years has been a director of, the following companies:

Current directorships/partnerships

Past directorships/partnerships

Cappo Inc

Gattaca Solutions Limited

Gattaca Information Technology Services SL

Matchtech Group (UK) Limited

Networkers Inc

 

Networkers International (Canada) Inc.

 

NWI de Mexico de RL de CV

 

 

Matt is currently holding 30,497 ordinary shares in the capital of the Company, equivalent to 0.09 per cent. of the Company's issued share capital. Save as set out in this announcement, there are no further details required to be disclosed pursuant to AIM Rule 17 or Schedule 2(g) to the AIM Rules in respect of Matt Wragg.

 

For further information please contact:

 

Gattaca plc

+44 (0) 1489 898989

Kevin Freeguard, Chief Executive Officer

Salar Farzad, Chief Financial Officer 

 

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Lauren Kettle

Robert Morton

 

Citigate Dewe Rogerson

Jos Bieneman

Lucy Eyles

 

 

+44 (0) 20 7638 9571

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZGMFNDZGZZM
Date   Source Headline
16th Apr 20247:00 amRNSInterim Results
2nd Apr 20247:00 amRNSBlock listing six monthly return
15th Feb 20247:00 amRNSTrading Update
25th Jan 20247:00 amRNSExercise of Options
6th Dec 20235:07 pmRNSDirector/PDMR Shareholding
6th Dec 20234:51 pmRNSResults of Annual General Meeting
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
15th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares
13th Nov 20237:00 amRNSContinuation of Share Buy-back
13th Nov 20237:00 amRNSAvailability of Report & Accounts and AGM Notice
25th Oct 20237:00 amRNSDirector/PDMR Share Purchase
25th Oct 20237:00 amRNSEBT Share Purchase Programme
24th Oct 20237:01 amRNSBoard Changes
24th Oct 20237:00 amRNSFinal results for the year ended 31 July 2023
17th Oct 20237:00 amRNSInvestor webinar 24 October 2023
2nd Oct 20239:00 amRNSBlock Listing Interim Review
25th Sep 20237:05 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSExercise of Options and Director/PDMR Shareholding
21st Sep 20237:00 amRNSTransaction in Own Shares
20th Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20237:00 amRNSTransaction in Own Shares
15th Sep 20237:00 amRNSTransaction in Own Shares
14th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20237:00 amRNSTransaction in Own Shares
12th Sep 20237:00 amRNSTransaction in Own Shares
11th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20232:05 pmRNSHolding(s) in Company
21st Aug 20237:00 amRNSLaunch of Share Buy-back
16th Aug 20237:00 amRNSTrading Update
12th May 20237:00 amRNSHolding(s) in Company
10th May 20237:00 amRNSTransaction in Own Shares
9th May 20237:00 amRNSTransaction in Own Shares
5th May 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.